After the clinical trial face-to-face interview, how far is the tumor patient from the clinical trial?

May 20, 2022 is the 18th "International Clinical Trial Day.

May 20, 2022 is the 18th "International Clinical Trial Day.

Clinical trials are the only way for new drugs to come to mark.

What suggestions and expectations do they have for the development of the clinical trial industry; what are the difficulties of clinical trials under the epidemic situation, and the countermeasures of all parties, the Medical Tumor GCP Center will listen to them on the occasion of the 18th International Clinical Trials D.

1--"Hospital she can't come to" She is in a medium and high-risk area and cannot go to Beijing for treatment 2--"Home that she can't go back to"

Uncle Wang, a patient with esophageal cancer, participated in a clinical trial of a new drug in February this ye.

The epidemic has hit the community where he lives, and he can't come and go at will except for medical treatme.

Controls restrict patients from being able to visit the hospital, do not want to seek medical treatment across provinces due to concerns about the epidemic, and shut down institutions or medical services under the epidemic

Sathian B, et .

3--"patient-centered"

3--"patient-centered"

In order to meet the treatment needs of clinical trial subjects under the dynamically changing epidemic situation, the GCP Center has successively issued the Guidelines for Post-Oral Medicine and Non-Oral Medicine Out-of-Hospital Treatment for the follow-up treatment of subjects in our hospital , as well as the non- "Guidelines for Assisting the Treatment of Non-Clinical Research Subjects in the Center" for the follow-up treatment of subjects in the cent.

"Guidelines for Oral Drug Mailing and Out-of-Hospital Treatment of Non-oral Drugs" "Guidelines for Assisting the Treatment of Non-Clinical Research Subjects in the Center"

In 2021, more than 300 subjects across 160 programs received mail-in medicati.

However, only less than 300 times of mailed medicines in the whole year are intravenous medicin.

How to establish a patient medication cooperation system under the epidemic is crucial, and this is also an important measure to shorten the "road" for cancer patients to clinical trials under the current situati.

The GCP Center has always called for the use of the multi-center model of clinical trials to build a good emergency cooperation system , and the center has opened up a green channel for "problem-oriented, using emergency to ensure safety"

Use the multi-center model of clinical trials to build a good emergency cooperation system "problem-oriented, use emergency to ensure safety" special green channel "everything is patient-centered"